EXJADE Side Effects

7022156-7 | Haematuria, Infection, Nephrolithiasis, Thrombocytopenia
on Sep 21, 2010 Male patient from UNITED STATES , weighting 187.0 lb, was diagnosed with iron overload, pain (What is pain?) and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: haematuria, infection (What is infection?), nephrolithiasis, thrombocytopenia. Exjade dosage: 250 Mg, Tid. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

7022148-8 | Guillain-barre Syndrome, Haemolytic Anaemia, Hypoaesthesia, Pulmonary Hypertension
Patient was taking Exjade (View Usage). Patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?), haemolytic anaemia, hypoaesthesia, pulmonary hypertension (What is pulmonary hypertension?) on Sep 20, 2010 from GREECE Additional patient health information: Female patient , 53 years of age, was diagnosed with thalassaemia, pulmonary hypertension (What is pulmonary hypertension?) and. Exjade dosage: 1500mg Daily. During the same period patient was treated with VOLIBRIS (Unk) (View Volibris Review and Volibris Label ), FILICINE (Unk) (View Filicine Review and Filicine Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), ONE ALPHA (Unk) (View One-alpha Review and One-alpha Label ), MEGA CALCIUM (Unk) (View Mega-calcium Review and Mega-calcium Label ), SINTROM (Unk) (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

7021116-X | Bacterial Sepsis, Cardio-respiratory Arrest, Pneumonia, Respiratory Failure, Septic Shock
Adverse event was reported on Sep 23, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 1000 Mg, Daily) was diagnosed with neoplasm and. Location: UNITED STATES , weighting 92.98 lb, After Exjade was administered, patient had the following side effects: bacterial sepsis, cardio-respiratory arrest, pneumonia (What is pneumonia?), respiratory failure, septic shock. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

7021109-2 | Alanine Aminotransferase Increased, Aortic Dilatation, Arteriosclerosis, Aspartate Aminotransferase Increased, Asthenia, Bacteraemia, Benign Prostatic Hyperplasia, Bladder Catheterisation, Blood Albumin Increased
on Sep 22, 2010 Male patient from UNITED STATES , weighting 143.3 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aortic dilatation, arteriosclerosis, aspartate aminotransferase increased, asthenia, bacteraemia, benign prostatic hyperplasia, bladder catheterisation, blood albumin increased. Exjade dosage: 1000 Mg, Qd. During the same period patient was treated with LISINOPRIL AND HYDROCHLOROTHIAZIDE (20/12.5 Mg Daily) (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), NIFEDIPINE (30 Mg, Qd) (View Nifedipine Review and Nifedipine Label ), FLUOXETINE (20 Mg, Qd) (View Fluoxetine Review and Fluoxetine Label ), DIGOXIN (125 Ug, Qd) (View Digoxin Review and Digoxin Label ), MULTI VITAMINS (1 Tablet Daily) (View Multi-vitamins Review and Multi-vitamins Label ), PROCRIT (20000 U, Unk) (View Procrit Review and Procrit Label ), LANTUS (22 U, Qd) (View Lantus Review and Lantus Label ). Patient was hospitalized.


7020686-5 | Haemoglobin Decreased, Pain, Sickle Cell Anaemia With Crisis, Transfusion Reaction, Treatment Noncompliance
on Sep 20, 2010 Male patient from UNITED STATES , weighting 106.7 lb, was diagnosed with sickle cell anaemia and was treated with Exjade (View Usage). Patient had the following side effects: haemoglobin decreased, pain (What is pain?), sickle cell anaemia with crisis, transfusion reaction, treatment noncompliance. Exjade dosage: 1000 Mg/day. Patient was hospitalized.

7020680-4 | Diarrhoea, Diverticulitis
Patient was taking Exjade (View Usage). After Exjade was administered, patient had the following side effects: diarrhoea, diverticulitis on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 118.6 lb, was diagnosed with myelodysplastic syndrome and. Exjade dosage: 1000 Mg Daily. During the same period patient was treated with TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), LEVOTHYROXINE SODIUM (Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

7018788-2 | Dizziness, Febrile Neutropenia, Haematocrit Decreased, Haemoglobin Decreased, Hypotension, Neutrophil Count Decreased, Platelet Count Decreased, Syncope, White Blood Cell Count Decreased
Adverse event was reported on Sep 16, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 250 Mg, Daily) was diagnosed with myelodysplastic syndrome, iron overload and. Location: UNITED STATES , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypotension, neutrophil count decreased, platelet count decreased, syncope, white blood cell count decreased. During the same period patient was treated with TYLENOL (View Tylenol Review and Tylenol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CITRACAL (View Citracal Review and Citracal Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), CHONDROITIN (View Chondroitin Review and Chondroitin Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

7018781-X | Infection, Pyrexia, Urine Colour Abnormal
on Sep 17, 2010 Female patient from UNITED STATES , weighting 138.6 lb, was diagnosed with sickle cell anaemia and was treated with Exjade (View Usage). Patient had the following side effects: infection (What is infection?), pyrexia, urine colour abnormal. Exjade dosage: 1250 Mg Daily. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

7018778-X |
on Sep 27, 2010 Male patient from UNITED STATES , weighting 240.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). . Exjade dosage: 2000mg/daily.

7018378-1 | Colonoscopy, Cough, Diarrhoea, Pyrexia, Rash, Sputum Culture Positive
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: colonoscopy (What is colonoscopy?), cough, diarrhoea, pyrexia, rash (What is rash?), sputum culture positive on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 238.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Exjade dosage: 500 Mg, Qid. During the same period patient was treated with ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PRILOSEC (View Prilosec Review and Prilosec Label ).

7018093-4 | Cerebral Infarction, Convulsion, Serum Ferritin Increased
Adverse event was reported on Sep 23, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 200 Mg, Qd) was diagnosed with sickle cell anaemia, pneumococcal infection, convulsion and. Location: UNITED STATES , weighting 111.5 lb, Patient had the following side effects: cerebral infarction, convulsion, serum ferritin increased. During the same period patient was treated with PEN VEE K (250 Mg, Bid) (View Pen-vee K Review and Pen-vee K Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), DEPAKOTE (2 Tabs Bid) (View Depakote Review and Depakote Label ).

7018032-6 | Bladder Disorder, Splenectomy
on Sep 17, 2010 Female patient from UNITED STATES , weighting 169.5 lb, was diagnosed with iron overload and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: bladder disorder, splenectomy. Exjade dosage: 3000 Mg. Patient was hospitalized.

7016816-1 | Acute Myeloid Leukaemia, Neutropenia, Pancytopenia, Platelet Count Decreased, Pneumonia Fungal
on Sep 21, 2010 Male patient from UNITED STATES , weighting 213.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, neutropenia, pancytopenia, platelet count decreased, pneumonia fungal. Exjade dosage: 2500 Mg Daily. During the same period patient was treated with ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CARBIDOPA + LEVODOPA (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), FIBERCON (POLYCARBOPHIL CALCIUM) (View Fibercon (polycarbophil Calcium) Review and Fibercon (polycarbophil Calcium) Label ), CENTRUM (View Centrum Review and Centrum Label ), DOXYCYCLINE (Unk) (View Doxycycline Review and Doxycycline Label ), AZITHROMYCIN (Unk) (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

7016688-5 | Bone Marrow Transplant
Patient was taking Exjade (View Usage). Patient had the following side effects: bone marrow transplant (What is bone marrow transplant?) on Sep 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 120.0 lb, was diagnosed with polycythaemia vera and. Exjade dosage: 1125 Mg Daily. Patient was hospitalized.

7016681-2 | Cardiac Failure Congestive, Liver Injury, Renal Impairment, Serum Ferritin Increased
Adverse event was reported on Jan 12, 2009 by a Female patient taking Exjade (View Usage) (Dosage: 1000 Mg Daily) . Location: UNITED STATES , weighting 129.2 lb, After Exjade was administered, patient had the following side effects: cardiac failure congestive, liver injury, renal impairment, serum ferritin increased. During the same period patient was treated with DIGOXIN (125 Mcg Daily) (View Digoxin Review and Digoxin Label ), LEVOTHYROXINE SODIUM (112 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CARVEDILOL (6.25 Mg, Bid) (View Carvedilol Review and Carvedilol Label ), HYDROXYUREA (500 Mg, Qd) (View Hydroxyurea Review and Hydroxyurea Label ), ALLOPURINOL (100 Mg, Bid) (View Allopurinol Review and Allopurinol Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), DEFERASIROX (1000 Mg, Qd) (View Deferasirox Review and Deferasirox Label ). Patient was hospitalized.

7016402-3 | Fall, Hip Fracture
on Sep 16, 2010 Male patient from UNITED STATES , weighting 172.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hip fracture. Exjade dosage: 750 Mg/day. During the same period patient was treated with AMIODARONE HCL (200 Mg, Qd) (View Amiodarone Hcl Review and Amiodarone Hcl Label ), CARDURA (4 Mg, Qd) (View Cardura Review and Cardura Label ), COLACE (Unk) (View Colace Review and Colace Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), GLYBURIDE (5 Mg, Bid) (View Glyburide Review and Glyburide Label ), KLOR CON (10 Mg, Bid) (View Klor-con Review and Klor-con Label ). Patient was hospitalized and became disabled.

7014697-3 | Chest Pain, Decreased Appetite, Diarrhoea, Oedema Peripheral
on Sep 06, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 38 years of age, was diagnosed with thalassaemia and was treated with Exjade (View Usage). Patient had the following side effects: chest pain (What is chest pain?), decreased appetite, diarrhoea, oedema peripheral. Exjade dosage: 8 Df, Qd.

7014431-7 | Cardioversion, Circulatory Collapse, Ventricular Fibrillation
Patient was taking Exjade (View Usage). After Exjade was administered, patient had the following side effects: cardioversion, circulatory collapse, ventricular fibrillation on Sep 22, 2010 from BELGIUM Additional patient health information: Female patient , 22 years of age, weighting 145.5 lb, was diagnosed with haemosiderosis and. Exjade dosage: 30 Mg/ Kg. During the same period patient was treated with ZESTRIL (View Zestril Review and Zestril Label ), KREDEX (View Kredex Review and Kredex Label ), BUMEX (View Bumex Review and Bumex Label ), FOLAVIT (View Folavit Review and Folavit Label ), ASAFLOW (View Asaflow Review and Asaflow Label ), SINTROM (View Sintrom Review and Sintrom Label ). Patient was hospitalized.

7012977-9 | Pancreatitis
Adverse event was reported on Sep 14, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 500 Mg, Qd) was diagnosed with sickle cell anaemia and. Location: UNITED KINGDOM , child 12 years of age, weighting 66.14 lb, Patient experienced the following unwanted or unexpected effects: pancreatitis. During the same period patient was treated with FOLIC ACID (5 Mg, Bid) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

7012409-0 | Back Pain, Pneumonia
on Sep 15, 2010 Female patient from UNITED STATES , weighting 120.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). Patient had the following side effects: back pain (What is back pain?), pneumonia (What is pneumonia?). Exjade dosage: 1125 Mg Daily. Patient was hospitalized.

7012386-2 |
on Sep 21, 2010 Female patient from UNITED STATES , weighting 141.1 lb, was diagnosed with iron overload and was treated with Exjade (View Usage). . Exjade dosage: 1250 Mg, Qd.

7011991-7 | Decreased Appetite, Fatigue, Haemoglobin Decreased, Nausea, Somnolence, Treatment Noncompliance
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, fatigue, haemoglobin decreased, nausea (What is nausea?), somnolence, treatment noncompliance on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 198.0 lb, was diagnosed with neoplasm and. Exjade dosage: 2000 Mg, Qd.

7009567-0 |
Adverse event was reported on Sep 20, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 1000 Mg, Daily) was diagnosed with neoplasm and. Location: UNITED STATES , weighting 112.0 lb, .

7009566-9 | Circulatory Collapse
on Sep 20, 2010 Female patient from BELGIUM , 22 years of age, was diagnosed with haemosiderosis and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: circulatory collapse. Exjade dosage: Unk. Patient was hospitalized.

7009521-9 | Pulmonary Oedema
on Sep 14, 2010 Female patient from UNITED STATES , weighting 107.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary oedema. Exjade dosage: 1000 Mg/day. Patient was hospitalized.

7009508-6 | Bone Marrow Transplant
Patient was taking Exjade (View Usage). Patient had the following side effects: bone marrow transplant (What is bone marrow transplant?) on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 41.89 lb, was diagnosed with sickle cell anaemia and. Exjade dosage: 625 Mg Daily. Patient was hospitalized.

7007994-9 | Diarrhoea, Platelet Count Decreased, Rash, Thrombosis, Upper Respiratory Tract Infection
Adverse event was reported on Sep 13, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 1250 Mg, Daily) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , weighting 128.0 lb, After Exjade was administered, patient had the following side effects: diarrhoea, platelet count decreased, rash (What is rash?), thrombosis, upper respiratory tract infection. During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

7007315-1 | Leukaemia, Malignant Neoplasm Progression
on Sep 20, 2010 Male patient from UNITED STATES , weighting 225.0 lb, was diagnosed with neoplasm and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: leukaemia, malignant neoplasm progression. Exjade dosage: 2000 Mg/day.

7007259-5 | Dizziness, Febrile Neutropenia, Syncope, Visual Impairment
on Sep 09, 2010 Female patient from UNITED STATES , weighting 139.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). Patient had the following side effects: dizziness (What is dizziness?), febrile neutropenia, syncope, visual impairment. Exjade dosage: 250 Mg, Daily. During the same period patient was treated with TYLENOL (View Tylenol Review and Tylenol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CITRACAL (View Citracal Review and Citracal Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), CHONDROITIN (View Chondroitin Review and Chondroitin Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

7007105-X |
Patient was taking Exjade (View Usage). on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with neoplasm and. Exjade dosage: Unk.

7007103-6 |
Adverse event was reported on Sep 18, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 500 Mg Daily) was diagnosed with iron overload and. Location: MEXICO , 55 years of age, .

7006682-2 | Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Dysmenorrhoea, Eye Pain, Haemoglobin Decreased, Mean Cell Volume Increased, Reticulocyte Count Increased, Sight Disability
on Aug 24, 2010 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with sickle cell anaemia, haemosiderosis and was treated with Exjade (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, dysmenorrhoea, eye pain, haemoglobin decreased, mean cell volume increased, reticulocyte count increased, sight disability. Exjade dosage: 1000 Mg, Qd. During the same period patient was treated with FOLIC ACID (1 Mg, Daily) (View Folic Acid Review and Folic Acid Label ), HYDROXYUREA (500 Mg, Daily) (View Hydroxyurea Review and Hydroxyurea Label ).

7006611-1 | Malaise
on Sep 13, 2010 Female patient from UNITED STATES , weighting 147.7 lb, was diagnosed with sickle cell anaemia and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: malaise. Exjade dosage: 1750 Mg/ Daily. Patient was hospitalized.

7001555-3 | Deep Vein Thrombosis
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?) on Sep 10, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 147.2 lb, was diagnosed with myelodysplastic syndrome, hypothyroidism and. Exjade dosage: 2000 Mg, Qd. During the same period patient was treated with SYNTHROID (100 Ug, Qd) (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

7001540-1 | Abscess Neck
Adverse event was reported on Sep 09, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 2000 Mg Daily) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , weighting 244.7 lb, Patient had the following side effects: abscess neck. Patient was hospitalized.

7001260-3 |
on Sep 16, 2010 Female patient from UNITED STATES , weighting 159.0 lb, was diagnosed with neoplasm and was treated with Exjade (View Usage). . Exjade dosage: 1500 Mg/day.

7001134-8 | Bone Marrow Transplant
on Sep 10, 2010 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with polycythaemia vera and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow transplant (What is bone marrow transplant?). Exjade dosage: 1125 Mg Daily. Patient was hospitalized.

6999562-X | Pancreatitis
Patient was taking Exjade (View Usage). Patient had the following side effects: pancreatitis on Sep 08, 2010 from UNITED KINGDOM Additional patient health information: Female patient , child 12 years of age, weighting 66.14 lb, . Exjade dosage: 500 Mg Daily.

6992438-3 | Asthenia, Back Pain, Blood Count Abnormal, Decreased Appetite, Feeling Abnormal, Fluid Retention, Renal Pain, Splenomegaly, Urine Colour Abnormal
Adverse event was reported on Sep 09, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 1500 Mg, Unk) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , weighting 222.4 lb, After Exjade was administered, patient had the following side effects: asthenia, back pain (What is back pain?), blood count abnormal, decreased appetite, feeling abnormal, fluid retention, renal pain, splenomegaly, urine colour abnormal. During the same period patient was treated with REVLIMID (15 Mg Twice Weekly) (View Revlimid Review and Revlimid Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), TRANSFUSIONS (View Transfusions Review and Transfusions Label ). Patient was hospitalized.

6992435-8 | Convulsion, Insomnia
on Sep 08, 2010 Male patient from FRANCE , 21 years of age, weighting 143.3 lb, was diagnosed with iron overload, haemochromatosis, epilepsy (What is epilepsy?) and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, insomnia. Exjade dosage: 1500 Mg/day. During the same period patient was treated with TOPIRAMATE (100 Mg, Tid For 3 Years) (View Topiramate Review and Topiramate Label ).

6992431-0 | Ulcerative Keratitis
on Sep 08, 2010 Female patient from UNITED STATES , weighting 194.0 lb, was diagnosed with myelodysplastic syndrome, iron overload and was treated with Exjade (View Usage). Patient had the following side effects: ulcerative keratitis. Exjade dosage: 500 Mg, Qod. During the same period patient was treated with VIDAZA (112mg Iv Daily X 5d) (View Vidaza Review and Vidaza Label ), METFORMIN (View Metformin Review and Metformin Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), NEXIUM (View Nexium Review and Nexium Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6991946-9 | Malignant Neoplasm Progression
Patient was taking Exjade (View Usage). After Exjade was administered, patient had the following side effects: malignant neoplasm progression on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 162.0 lb, was diagnosed with myelodysplastic syndrome and. Exjade dosage: 1500 Mg, Qd.

6991941-X | Malaise
Adverse event was reported on Sep 13, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 1500 Mg, Qd) was diagnosed with multiple myeloma (What is multiple myeloma?), neoplasm and. Location: UNITED STATES , weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: malaise. Patient was hospitalized.

6991929-9 | Therapeutic Procedure
on Sep 08, 2010 Female patient from UNITED STATES , weighting 41.89 lb, was diagnosed with sickle cell anaemia and was treated with Exjade (View Usage). Patient had the following side effects: therapeutic procedure. Exjade dosage: 625 Mg Daily. Patient was hospitalized.

6991919-6 | Abdominal Discomfort, Activities Of Daily Living Impaired, Headache, Influenza Like Illness, Liver Transplant, Nausea, Oropharyngeal Pain, Vertigo
on Sep 02, 2010 Female patient from UNITED STATES , weighting 156.5 lb, was diagnosed with haemochromatosis and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: abdominal discomfort, activities of daily living impaired, headache (What is headache?), influenza like illness, liver transplant (What is liver transplant?), nausea (What is nausea?), oropharyngeal pain, vertigo. Exjade dosage: 1250 Mg, Qd/ 20 Mg Per Kg. During the same period patient was treated with BLOOD CELLS, PACKED HUMAN (View Blood Cells, Packed Human Review and Blood Cells, Packed Human Label ), IMMUNOSUPPRESSANTS (View Immunosuppressants Review and Immunosuppressants Label ), HIGH FERRITIN TRANSFUSION NEED (View High Ferritin Transfusion Need Review and High Ferritin Transfusion Need Label ).

6987806-X | Bone Marrow Transplant, Psychotic Disorder
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow transplant (What is bone marrow transplant?), psychotic disorder (What is psychotic disorder?) on Sep 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 185.0 lb, was diagnosed with sickle cell anaemia and. Exjade dosage: 1500 Mg, Qd. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6987439-5 | Angina Pectoris, Decreased Appetite, Diarrhoea, Oedema Peripheral
Adverse event was reported on Sep 06, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 8 Df, Qd) was diagnosed with thalassaemia and. Location: TAIWAN, PROVINCE OF CHINA , 38 years of age, Patient had the following side effects: angina pectoris, decreased appetite, diarrhoea, oedema peripheral.

6987396-1 | Biopsy, Blood Alkaline Phosphatase Increased, Blood Phosphorus Decreased, Bone Density Decreased, Bone Marrow Disorder, Osteoporosis, Osteoporotic Fracture, Renal Tubular Disorder
on Sep 02, 2010 Female patient from GERMANY , weighting 130.1 lb, was diagnosed with myelodysplastic syndrome, cytogenetic abnormality and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: biopsy, blood alkaline phosphatase increased, blood phosphorus decreased, bone density decreased, bone marrow disorder, osteoporosis (What is osteoporosis?), osteoporotic fracture, renal tubular disorder. Exjade dosage: 1000 Mg Daily. During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ).

6985074-6 | Blood Creatinine Increased, Dialysis
on Sep 03, 2010 Male patient from UNITED STATES , weighting 245.0 lb, was diagnosed with iron overload and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, dialysis (What is dialysis?). Exjade dosage: 500 Mg, Bid. During the same period patient was treated with ACIPHEX (20 Mg, Qd) (View Aciphex Review and Aciphex Label ), ASPIRIN (325 Mg, Qd) (View Aspirin Review and Aspirin Label ), CARTIA XT (120 Mg, Unk) (View Cartia Xt Review and Cartia Xt Label ), COZAAR (100 Mg, Qd) (View Cozaar Review and Cozaar Label ), DESFERAL (1000 Mg, Unk) (View Desferal Review and Desferal Label ), FOLIC ACID (1 Mg, Bid) (View Folic Acid Review and Folic Acid Label ), LASIX (40 Mg, Bid) (View Lasix Review and Lasix Label ). Patient was hospitalized.

6985069-2 | Arthritis, Infection
Patient was taking Exjade (View Usage). Patient had the following side effects: arthritis (What is arthritis?), infection (What is infection?) on Sep 03, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 72.99 lb, was diagnosed with neoplasm and. Exjade dosage: 2000 Mg, Qd. Patient was hospitalized.